Get new similar jobs by email for
IT Project Manager/Business An...
Auxilium Pharmaceuticals, Inc. is seeking a IT Project Manager/Business Analyst to join its team in our Chesterbrook office. The IT Project Manager/Business Analyst will be responsible for the optimal use of existing and new systems and solutions. This includes changing and optimizing processes as well reconfiguring the systems to ensure fit within Auxilium's IT landscape.
AREAS OF RESPONSIBILITY
EDUCATION & TRAINING
SKILLS & BEHAVIORS
Auxilium Pharmaceuticals, Inc. is a fully integrated specialty biopharmaceutical company with a focus on developing and commercializing products to predominantly specialist audiences. Auxilium markets Testim (testosterone gel) for the topical treatment of hypogonadism in the U.S. and XIAFLEX (collagenase clostridium histolyticum (CCH) for the treatment of adult men with Peyronie’s disease with a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy in the U.S., and XIAFLEX for the treatment of adult Dupuytren’s contracture patients with a palpable cord in the U.S. Ferring International Center S.A. markets Testim in certain countries of the EU and Paladin Labs Inc. markets Testim in Canada. Swedish Orphan Biovitrium AB has marketing rights for XIAPEX® (the EU tradename for CCH) in 71 Eurasian and African countries. Asahi Kasei Pharma Corporation has development and commercial rights for XIAFLEX in Japan and Actelion Pharmaceuticals Ltd has development and commercial rights for XIAFLEX in Canada, Australia, Brazil and Mexico. Auxilium also markets TESTOPEL®, a long-acting implantable testosterone replacement therapy, Edex®, the leading branded non-oral drug for erectile dysfunction, Striant®, a buccal system for testosterone delivery, Osbon ErecAid®, the leading device for aiding erectile dysfunction, and also has a non-promoted respiratory franchise, including Theo-24® and Semprex®-D, along with other non-promoted products, in the U.S. Auxilium has exclusive marketing rights in the U.S. and Canada for STENDRA™, an oral erectile dysfunction therapy. Auxilium has two projects in clinical development. CCH is in Phase 2 of development for the treatment of Frozen Shoulder syndrome (adhesive capsulitis) and Phase 2 of development for the treatment of cellulite (edematous fibrosclerotic panniculopathy). Auxilium also has rights to pursue additional indications for XIAFLEX. For additional information, visit http://www.auxilium.com.
In addition to competitive salaries, Auxilium offers eligible employees a comprehensive benefits package that includes: healthcare coverage, prescription drug plan, dental plan, short- and long-term disability, long-term care coverage, flexible spending accounts, life insurance, 401(k) with company matching, and tuition reimbursement.
Auxilium is an equal opportunity employer that recruits, hires, trains and promotes persons in all positions without regard to race, color, religion, sex, marital status, age, sexual orientation, national origin, ancestry, physical handicap, citizenship, veteran status or any other unlawful basis.